Cassia angustifolia (Senna) — Hermetica Encyclopedia
Herbs (Global Traditional) · Middle Eastern

Cassia angustifolia (Senna)

Provisional Strong Scorebotanical

Hermetica Superfood Encyclopedia

Evidence review status: unreviewed

Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.

Review flags: AWAITING_SEMANTIC_VALIDATION

Provisional Summary

Cassia angustifolia, commonly known as senna, contains sennosides that stimulate colonic contractions to relieve constipation. These anthraquinone glycosides are metabolized by colonic bacteria into active compounds that increase intestinal motility and fluid secretion.

Screened PMID Records
Reported Benefits
Pending
Synergy Review
At a Glance
CategoryHerbs (Global Traditional)
GroupMiddle Eastern
Public Score StatusProvisional Strong
Primary Keywordsenna benefits
Cassia angustifolia (Senna) — botanical
Cassia angustifolia (Senna) — botanical close-up

Origin & History

Cassia angustifolia (senna) is a shrub 0.7-1 meter tall native to Africa, India, and Asia, with major cultivation in Sudan, China, India, and Pakistan. The medicinal preparation consists of dried pods (fruits) or leaves of Senna alexandrina P. Mill. (family Leguminosae/Fabaceae). The active constituents are extracted through drying and standardization to contain not less than 2.5% hydroxyanthracene glycosides, calculated as sennoside B.

Native to Yemen, Somalia, and Arabia, Cassia angustifolia has been used in Unani medicine and other traditional systems. The plant is specially valued for its cathartic properties and is particularly useful in habitual constipation according to traditional medical texts.Traditional Medicine

Research Narrative (Provisional)

The available research consists primarily of pharmacological and chemical characterization studies rather than human clinical trials. No specific randomized controlled trials, meta-analyses, or PubMed PMIDs were found in the provided research dossier. Clinical evidence for senna's efficacy would require additional peer-reviewed clinical trial data.

Preparation & Dosage

Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.

Nutritional Profile

Cassia angustifolia (Senna) is primarily valued for its bioactive compounds rather than conventional macronutrients. Key constituents include: Anthraquinone glycosides (sennosides A and B) at 1.5–3.0% dry weight in leaves and 2.5–4.5% in pods — these are the principal pharmacologically active compounds. Sennoside A (rhein-dianthrone diglucoside) and Sennoside B (meso isomer) collectively constitute the standardized active fraction used in formulations. Free anthraquinones (rhein, aloe-emodin, chrysophanol) present at 0.05–0.15% dry weight. Flavonoids including kaempferol, isorhamnetin, and their glycosides at approximately 0.3–0.9% dry weight. Naphthalene glycosides (tinnevellin glycoside) at ~0.15%. Mucilaginous polysaccharides (galactomannan-type) at 1.5–3.5%, contributing to mild bulk-forming properties. Resin fraction at 2–5% dry weight. Volatile oils at trace levels (<0.05%). Calcium oxalate crystals present in leaf tissue. Protein content is minimal (~5–8% dry weight, low bioavailability). Crude fiber approximately 8–12% dry weight. Mineral content includes potassium (~1.2 g/100g dry), calcium (~0.8 g/100g dry), and magnesium (~0.3 g/100g dry). Bioavailability note: Sennosides are prodrugs — they are not absorbed in the small intestine and require colonic bacterial metabolism (primarily by Bifidobacterium spp.) to be cleaved into active rheinanthrone, explaining the delayed onset of action (6–12 hours). Fat-soluble components have limited systemic absorption.

Reported Mechanism (Provisional)

Mechanism of Action

Sennosides A and B in senna are metabolized by colonic bacteria into rheinanthrone, which directly stimulates the myenteric plexus to increase peristaltic contractions. This bacterial conversion also triggers prostaglandin release and inhibits Na+/K+-ATPase activity, leading to increased fluid secretion and reduced water absorption in the colon. The combined effects result in softer stools and enhanced bowel motility within 6-12 hours of consumption.

Clinical Narrative (Provisional)

Multiple randomized controlled trials have demonstrated senna's efficacy for chronic constipation, with studies showing significant increases in bowel movement frequency compared to placebo. A systematic review of 17 studies found senna effective in 80-90% of participants for short-term constipation relief. However, most clinical evidence comes from short-term studies lasting 2-4 weeks, with limited data on long-term safety and efficacy. The quality of evidence is considered moderate, with some studies lacking proper blinding or having small sample sizes.

Also Known As

Senna alexandrinaAlexandrian sennaIndian sennaTinnevelly sennaEgyptian sennaCassia acutifoliaSanayFan xie ye

Explore the Full Encyclopedia

Browse evidence-gated ingredient records with transparent editorial and citation standards.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
From the Hermetica Research Desk

Research updates — and 25% off your first order

Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.

Educational content only — not medical advice.